Calidi Biotherapeutics Inc. Financial Flexibility Index
Calidi Biotherapeutics Inc. financial flexibility index. Calidi Biotherapeutics Inc. (CLDI) has a Financial Flexibility Index of -0.98x as of December 2025. Free cash flow of $-5.01 Million (operating CF $-5.04 Million minus capex $29.00K) represents -1% of total liabilities ($5.10 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Calidi Biotherapeutics Inc. (2020–2025)
Financial flexibility index of Calidi Biotherapeutics Inc. from 2020 to 2025. Historical Financial Flexibility Index trend for Calidi Biotherapeutics Inc. across 6 annual periods. Explore Calidi Biotherapeutics Inc. (CLDI) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Calidi Biotherapeutics Inc. Financial Flexibility Index by Year (2020–2025)
Calidi Biotherapeutics Inc. financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for Calidi Biotherapeutics Inc.. For the full cash flow conversion analysis, see Calidi Biotherapeutics Inc. cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.15x | $-21.17 Million | $-21.29 Million | $5.10 Million | ▼ -157.8% |
| 2024 | -1.61x | $-19.68 Million | $-19.69 Million | $12.21 Million | ▼ -11.4% |
| 2023 | -1.45x | $-26.40 Million | $-26.98 Million | $18.25 Million | ▼ -499.9% |
| 2022 | -0.24x | $-12.79 Million | $-13.21 Million | $53.04 Million | ▲ +17.2% |
| 2021 | -0.29x | $-7.57 Million | $-7.77 Million | $26.00 Million | ▼ -58.3% |
| 2020 | -0.18x | $-4.47 Million | $-4.83 Million | $24.33 Million | — |